AustralianSuper’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $5.67M | Buy |
+8,397
| New | +$4.99M | 0.02% | 216 |
|
|
2025
Q3 | – | Sell |
-8,790
| Closed | -$3.56M | – | 294 |
|
|
2025
Q2 | $3.56M | Sell |
8,790
-2,791
| -24% | -$1.17M | 0.02% | 213 |
|
|
2025
Q1 | $5.76M | Hold |
11,581
| – | – | 0.03% | 167 |
|
|
2024
Q4 | $6.02M | Sell |
11,581
-127,147
| -92% | -$69.9M | 0.03% | 163 |
|
|
2024
Q3 | $85.8M | Buy |
138,728
+127,750
| +1,164% | +$75.6M | 0.43% | 66 |
|
|
2024
Q2 | $6.07M | Buy |
10,978
+263
| +2% | +$151K | 0.04% | 136 |
|
|
2024
Q1 | $6.19M | Hold |
10,715
| – | – | 0.04% | 140 |
|
|
2023
Q4 | $5.69M | Sell |
10,715
-233,067
| -96% | -$113M | 0.03% | 158 |
|
|
2023
Q3 | $123M | Buy |
243,782
+1,073
| +0.4% | +$572K | 0.8% | 34 |
|
|
2023
Q2 | $127M | Buy |
242,709
+47,505
| +24% | +$25.6M | 0.8% | 34 |
|
|
2023
Q1 | $113M | Buy |
195,204
+13,872
| +8% | +$7.82M | 0.69% | 38 |
|
|
2022
Q4 | $100M | Sell |
181,332
-208,096
| -53% | -$110M | 0.67% | 40 |
|
|
2022
Q3 | $198M | Buy |
389,428
+185,903
| +91% | +$104M | 1.41% | 24 |
|
|
2022
Q2 | $111M | Sell |
203,525
-306,891
| -60% | -$169M | 0.68% | 39 |
|
|
2022
Q1 | $301M | Sell |
510,416
-66,458
| -12% | -$38.2M | 1.64% | 19 |
|
|
2021
Q4 | $357M | Buy |
576,874
+1,183
| +0.2% | +$739K | 1.85% | 13 |
|
|
2021
Q3 | $329M | Sell |
575,691
-74,232
| -11% | -$40.7M | 2.11% | 11 |
|
|
2021
Q2 | $328M | Hold |
649,923
| – | – | 2.29% | 10 |
|
|
2021
Q1 | $297M | Hold |
649,923
| – | – | 2.32% | 11 |
|
|
2020
Q4 | $303M | Sell |
649,923
-44,198
| -6% | -$20.7M | 2.27% | 10 |
|
|
2020
Q3 | $306M | Buy |
694,121
+30,234
| +5% | +$12.5M | 2.62% | 8 |
|
|
2020
Q2 | $241M | Sell |
663,887
-47,962
| -7% | -$16.1M | 2.33% | 9 |
|
|
2020
Q1 | $202M | Sell |
711,849
-183,265
| -20% | -$57.8M | 2.59% | 9 |
|
|
2019
Q4 | $291M | Sell |
895,114
-96,005
| -10% | -$29.1M | 2.45% | 7 |
|
|
2019
Q3 | $289M | Hold |
991,119
| – | – | 2.73% | 8 |
|
|
2019
Q2 | $291M | Sell |
991,119
-51,981
| -5% | -$14.3M | 2.8% | 6 |
|
|
2019
Q1 | $286M | Hold |
1,043,100
| – | – | 2.98% | 5 |
|
|
2018
Q4 | $233M | Buy |
1,043,100
+104,100
| +11% | +$24.4M | 3.63% | 6 |
|
|
2018
Q3 | $229M | Buy |
939,000
+100,000
| +12% | +$23M | 4.34% | 6 |
|
|
2018
Q2 | $174M | Buy |
839,000
+78,801
| +10% | +$16.7M | 4.08% | 7 |
|
|
2018
Q1 | $157M | Hold |
760,199
| – | – | 4.98% | 5 |
|
|
2017
Q4 | $144M | Buy |
760,199
+70,301
| +10% | +$13.5M | 5.24% | 5 |
|
|
2017
Q3 | $131M | Buy |
689,898
+292,398
| +74% | +$53M | 5.9% | 1 |
|
|
2017
Q2 | $69.4M | Buy |
397,500
+73,500
| +23% | +$12.3M | 5.33% | 7 |
|
|
2017
Q1 | $49.8M | Buy |
+324,000
| New | +$49.5M | 5.7% | 8 |
|
Other funds holding TMO
AustralianSuper's TMO Position: Q3 2026 in Review
AustralianSuper opened a new position in Thermo Fisher Scientific (TMO) in Q3 2026: 8,397 shares worth $5.67M. The stake represents 0.02% of the portfolio and ranks #216 among its holdings. This is a return to the name: AustralianSuper previously reported a position in TMO as recently as Q2 2025.
AustralianSuper first reported a position in TMO in Q1 2017 and has held it in 35 quarters since. The position peaked at $357M in Q4 2021. 2,450 funds tracked by Wall St. Rank hold TMO as of Q3 2026.
- AustralianSuper held 8,397 shares of Thermo Fisher Scientific worth $5.67M as of Q3 2026.
- Thermo Fisher Scientific was a new AustralianSuper position in Q3 2026.
- Thermo Fisher Scientific made up 0.02% of AustralianSuper's portfolio in Q3 2026, its #216 holding.
- AustralianSuper first reported a position in Thermo Fisher Scientific in Q1 2017 and has held it in 35 quarters since.
- AustralianSuper's Thermo Fisher Scientific position peaked at $357M in Q4 2021.
- 2,450 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.
Based on AustralianSuper's 13F filing for Q3 2026, filed 10 Nov 2026.